Supplier News Breaks Archives

Week of Mon, Apr 23rd, 2012

VIVUS cleared to market ED drug

VIVUS Inc. has received approval from the Food and Drug Administration for Stendra tablets (avanafil), indicated for the treatment of erectile dysfunction (ED).

Serena Williams serves up Sleep Sheets at Walgreens

Tennis star Serena Williams has introduced Sleep Sheets, a new natural sleep aid from Sheets Brand available exclusively at Walgreens.

Watson unveils deal to acquire Actavis

Watson Pharmaceuticals Inc. plans to buy Actavis Group for 4.25 billion euros ($5.6 billion).

Schick Intuition social media effort touts 'simplicity'

Schick Intuition has launches The Simplicity Project, an initiative on Facebook designed to help women make their lives easier.

Pepsi MAX kicks off 'Field of Dreams' promo

PepsiCo's Pepsi MAX brand is giving baseball fans a chance to take the field with Major League Baseball legends in the Pepsi MAX MLB Field of Dreams program.

Mylan, Dr. Reddy's launch Zyprexa generics

Mylan Inc. and Dr. Reddy’s Laboratories have released olanzapine tablets, an antipsychotic medication, in six dosage strengths.

Bud Light Lime adds 'Lime-A-Rita'

Anheuser-Busch is expanding its Bud Light lineup with Bud Light Lime Lime-a-Rita, which the company said gives a fresh twist to a classic summer cocktail, the margarita.

AstraZeneca to acquire Ardea Biosciences

AstraZeneca plans to buy Ardea Biosciences Inc. in a cash deal valued at $1.26 billion.

Pfizer sells pediatric nutrition business to Nestle

Pfizer has unveiled a deal to sell its pediatric nutrition business to Nestle for $11.85 billion in cash.

Watson ships authorized generic of Fortamet

Watson Pharmaceuticals Inc. has launched an authorized generic version of Fortamet, a treatment for type 2 diabetes.